You have access
Phase I Study of the Pan-PI3K Inhibitor Buparlisib in Adult Chinese Patients with Advanced Solid Tumors
YI-LONG WU, LI ZHANG, LUCIA TRANDAFIR, TUOCHUAN DONG, VINCENT DUVAL, KATHARINE HAZELL and BINGHE XU
Anticancer Research November 2016, 36 (11) 6185-6194;